• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一类PAI-2抑制剂(米那激活素)对组织型纤溶酶原激活剂的聚-D-赖氨酸依赖性失活作用

Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin).

作者信息

Leung K C, Byatt J A, Stephens R W

出版信息

Thromb Res. 1987 Jun 15;46(6):767-77. doi: 10.1016/0049-3848(87)90069-7.

DOI:10.1016/0049-3848(87)90069-7
PMID:3114909
Abstract

Two-chain tissue plasminogen activator (t-PA) was found to be inactive in a coupled colorimetric assay for plasminogen activators, but a high level of activity was obtained in the presence of poly-D-lysine. This stimulated activity was strongly inhibited by minactivin, a urokinase inhibitor, but unstimulated enzyme could be shown to be unaffected by minactivin. In the presence of poly-D-lysine minactivin was a very successful competitive inhibitor of t-PA with respect to the substrate, plasminogen. The Ki for minactivin determined by the Henderson method was 2.5 X 10(-12) M, compared to the Km for plasminogen determined as 0.6 X 10(-6) M. The value of Ki for minactivin with u-PA, determined under the same conditions, was 1.6 X 10(-11) M.

摘要

在纤溶酶原激活剂的比色偶联测定中,发现双链组织型纤溶酶原激活剂(t-PA)无活性,但在聚-D-赖氨酸存在的情况下可获得高水平的活性。这种刺激活性受到尿激酶抑制剂米那司亭的强烈抑制,但未受刺激的酶不受米那司亭影响。在聚-D-赖氨酸存在的情况下,米那司亭是t-PA针对底物纤溶酶原的非常有效的竞争性抑制剂。通过亨德森方法测定的米那司亭的Ki为2.5×10(-12)M,而测定的纤溶酶原的Km为0.6×10(-6)M。在相同条件下测定的米那司亭对尿激酶型纤溶酶原激活剂(u-PA)的Ki值为1.6×10(-11)M。

相似文献

1
Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin).一类PAI-2抑制剂(米那激活素)对组织型纤溶酶原激活剂的聚-D-赖氨酸依赖性失活作用
Thromb Res. 1987 Jun 15;46(6):767-77. doi: 10.1016/0049-3848(87)90069-7.
2
The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class PAI-2 inhibitor (minactivin).纤维蛋白刺激的组织型纤溶酶原激活物对PAI-2类抑制剂(米那司亭)灭活的抗性。
Thromb Res. 1987 Jun 15;46(6):755-66. doi: 10.1016/0049-3848(87)90068-5.
3
Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
Eur J Biochem. 1983 Nov 15;136(3):517-22. doi: 10.1111/j.1432-1033.1983.tb07771.x.
4
Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.纤溶酶原激活物抑制剂1型和2型对组织型和尿激酶型纤溶酶原激活物的抑制动力学
Eur J Biochem. 1988 Jul 15;175(1):33-9. doi: 10.1111/j.1432-1033.1988.tb14162.x.
5
Amiloride selectively inhibits the urokinase-type plasminogen activator.
FEBS Lett. 1987 Apr 6;214(1):187-91. doi: 10.1016/0014-5793(87)80039-x.
6
Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation.人结肠癌中纤溶酶原向尿激酶型纤溶酶原激活剂的转化:蛋白水解激活后单核细胞微小激活素的体外抑制作用
Eur J Cancer Clin Oncol. 1987 Feb;23(2):213-22. doi: 10.1016/0277-5379(87)90017-4.
7
A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.一种环肽类自杀底物优先使尿激酶型纤溶酶原激活剂失活。
Biochem Biophys Res Commun. 1991 Jul 15;178(1):352-9. doi: 10.1016/0006-291x(91)91821-s.
8
[Structure, function and use of fibrinolysis-promoting and inhibiting factors].[纤溶促进因子与纤溶抑制因子的结构、功能及应用]
Arzneimittelforschung. 1988 Mar;38(3A):474-8.
9
Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay.
Thromb Res. 1988 Apr 1;50(1):91-101. doi: 10.1016/0049-3848(88)90177-6.
10
Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.组织型纤溶酶原激活剂和尿激酶原的互补作用模式,据此可解释它们对血栓溶解的协同效应。
J Clin Invest. 1988 Mar;81(3):853-9. doi: 10.1172/JCI113394.

引用本文的文献

1
Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.编码人单核细胞源性纤溶酶原激活物抑制剂的cDNA的克隆与表达
Proc Natl Acad Sci U S A. 1988 Feb;85(4):985-9. doi: 10.1073/pnas.85.4.985.
2
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.人横纹肌肉瘤细胞表面的纤溶酶原激活物原激活:重组2类纤溶酶原激活物抑制剂对新形成的尿激酶型纤溶酶原激活物的定位和失活作用
Proc Natl Acad Sci U S A. 1990 Mar;87(6):2230-4. doi: 10.1073/pnas.87.6.2230.